Cargando…
Variable Increased Expression of Program Death-1 and Program Death-1 Ligands on Peripheral Mononuclear Cells Is Not Impaired in Patients with Systemic Lupus Erythematosus
Programmed death-1 (PD-1) was shown to deliver an inhibitory signal after binding to its ligands, PD-L1 (B7-H1) or PD-L2 (B7-DC). Recently, up-regulated expression of PD-1 molecule and/or its ligands was demonstrated in human diseases including rheumatoid arthritis and inflammatory colitis. The stud...
Autores principales: | Liu, Ming-Fei, Weng, Chia-Tse, Weng, Meng-Yu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744882/ https://www.ncbi.nlm.nih.gov/pubmed/19759858 http://dx.doi.org/10.1155/2009/406136 |
Ejemplares similares
-
Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Bertsias, G, et al.
Publicado: (2005) -
Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019) -
Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus
por: Yang, Fangyuan, et al.
Publicado: (2019) -
Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk
por: Gao, Jie, et al.
Publicado: (2017) -
Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus
por: Park, Min-Jung, et al.
Publicado: (2021)